SynaptixBio
Oxford · Founded 2021
About SynaptixBio
SynaptixBio is developing lifesaving therapies for severe leukodystrophies. The company enables the translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Their updated news is imported into the website. The customer queries are addressed through an online form.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Aug 2024)
- Website: https://www.synaptixbio.com
Industries & Categories
Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/synaptixbio-77051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.